News

LatestNews

OMass Therapeutics Expands its Senior Leadership Team
November 27, 2018

Dr Ali Jazayeri – Chief Scientific Officer Dr Giles Brown – VP, Medicinal Chemistry Dr Hsin Loke – VP, Head of…

Read More
OMass Therapeutics Announces £14 Million Series A Financing to Build a Pipeline of Proprietary Medicines
November 21, 2018

– Developing novel medicines using structural mass spectrometry – Oxford, 20 November 2018 – OMass Therapeutics (“OMass”), a biopharmaceutical company using…

Read More
OMass Therapeutics is Expanding its Team
November 20, 2018

Oxford, 20 November 2018 – OMass Therapeutics (“OMass”), a biotechnology company using structural mass spectrometry to discover novel medicines is expanding…

Read More
OMass Technologies Announces Publication Demonstrating the Impact of Lipid interactions on GPCR Signalling in Nature
July 11, 2018

Oxford, 11 July 2018 – OMass Technologies (“OMass”), a biotechnology company using structural mass spectrometry to drive drug discovery, today announced…

Read More